Associations of iron deficiency with cardiac function, congestion, exercise capacity and prognosis in heart failure

被引:4
作者
De Biase, Nicolo [1 ]
Del Punta, Lavinia [1 ]
L'Hoyes, Wouter [2 ]
Pellicori, Pierpaolo [3 ]
Cleland, John G. F. [3 ]
Masini, Gabriele [4 ]
Gargani, Luna [4 ]
Moura-Ferreira, Sara [2 ,5 ]
Hoedemakers, Sarah [2 ,5 ]
Di Fiore, Valerio [1 ]
Herbots, Lieven [2 ]
Stassen, Jan [2 ]
Mengozzi, Alessandro [1 ]
Armenia, Silvia [1 ]
Taddei, Stefano [1 ]
Masi, Stefano [1 ]
Verwerft, Jan [2 ]
Pugliese, Nicola Riccardo [1 ]
机构
[1] Univ Pisa, Dept Clin & Expt Med, Via Roma 67, I-56126 Pisa, Italy
[2] Jessa Hosp, Dept Cardiol, Hasselt, Belgium
[3] Univ Glasgow, Sch Cardiovasc & Metab Hlth, Glasgow, Scotland
[4] Azienda Osped Univ Pisana, Cardiac Thorac & Vasc Dept, Pisa, Italy
[5] UHasselt, Fac Rehabil Sci, Rehabil Res Ctr, Diepenbeek, Belgium
关键词
Iron deficiency; Heart failure; Heart failure with preserved ejection fraction; Exercise capacity; Congestion; Prognosis; FERRIC CARBOXYMALTOSE; PREVALENCE; ANEMIA; ECHOCARDIOGRAPHY; CARDIOPULMONARY; DIAGNOSIS; THERAPY;
D O I
10.1002/ejhf.3534
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Uncertainty exists about defining true iron deficiency (ID) in heart failure (HF) patients. We assessed the relationship of different ID definitions with cardiac structure and function, congestion, exercise capacity, and prognosis in HF outpatients. Methods and results Iron deficiency was defined according to guidelines (G-ID: ferritin <100 ng/ml or ferritin 100-299 ng/ml with transferrin saturation [TSAT] <20%). Alternative ID definitions based on TSAT (<20%), iron (<= 13 mu mol/L), and ferritin (<100 or < 300 ng/ml) were explored. Relationships with rest/exercise measures of cardiac function and congestion using ultrasound, effort intolerance and adverse outcome (HF hospitalizations or all-cause mortality) were assessed. Of 1502 patients (72% with left ventricular ejection fraction [LVEF] >= 50%), 471 (31%) had TSAT <20%, while 728 (48%) had G-ID. Patients with TSAT <20% or G-ID had greater left atrial volume but similar LVEF. Lower TSAT, iron and haemoglobin, but not ferritin, were associated with more signs of congestion by ultrasound. After correcting for multiple clinical variables, including haemoglobin, TSAT was directly associated with peak oxygen uptake (standardized coefficient 0.069, p = 0.041), while ferritin was not. There was no interaction with HF phenotype (HF with preserved vs. reduced LVEF). During a median follow-up of 18 months, TSAT <20% and iron <= 13 mu mol/L were associated with worse outcomes in models adjusted for clinical variables, including LVEF and N-terminal pro-B-type natriuretic peptide (hazard ratio 2.48, 95% confidence interval 1.88-3.17 and 1.93, 1.48-2.52, respectively), while G-ID or ferritin <100 or <300 ng/ml were not. Conclusion In HF outpatients, TSAT <20% is more consistently associated with congestion by ultrasound and poorer functional capacity than other ID definitions, irrespective of LVEF. TSAT <20% and iron <= 13 mu mol/L, but not G-ID or ferritin-based ID, predict a worse prognosis in HF outpatients with preserved and reduced LVEF.
引用
收藏
页码:889 / 900
页数:12
相关论文
共 49 条
[1]   Additional burden of iron deficiency in heart failure patients beyond the cardio-renal anaemia syndrome: findings from the BIOSTAT-CHF study [J].
Alnuwaysir, Ridha I. S. ;
Beverborg, Niels Grote ;
Hoes, Martijn F. ;
Markousis-Mavrogenis, George ;
Gomez, Karla A. ;
van der Wal, Haye H. ;
Cleland, John G. F. ;
Dickstein, Kenneth ;
Lang, Chim C. ;
Ng, Leong L. ;
Ponikowski, Piotr ;
Anker, Stefan D. ;
van Veldhuisen, Dirk J. ;
Voors, Adriaan A. ;
van der Meer, Peter .
EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (01) :192-204
[2]   Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies [J].
Anand, Inder S. ;
Gupta, Pankaj .
CIRCULATION, 2018, 138 (01) :80-98
[3]   Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency. [J].
Anker, Stefan D. ;
Comin Colet, Josep ;
Filippatos, Gerasimos ;
Willenheimer, Ronnie ;
Dickstein, Kenneth ;
Drexler, Helmut ;
Luescher, Thomas F. ;
Bart, Boris ;
Banasiak, Waldemar ;
Niegowska, Joanna ;
Kirwan, Bridget-Anne ;
Mori, Claudio ;
Rothe, Barbara von Eisenhart ;
Pocock, Stuart J. ;
Poole-Wilson, Philip A. ;
Ponikowski, Piotr .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (25) :2436-2448
[4]   Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis [J].
Beale, Anna L. ;
Warren, Josephine Lillian ;
Roberts, Nia ;
Meyer, Philippe ;
Townsend, Nick P. ;
Kaye, David .
OPEN HEART, 2019, 6 (01)
[5]   Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure Patients [J].
Beverborg, Niels Grote ;
Klip, IJsbrand T. ;
Meijers, Wouter C. ;
Voors, Adriaan A. ;
Vegter, Eline L. ;
van der Wal, Haye H. ;
Swinkels, Dorine W. ;
van Pelt, Joost ;
Mulder, Andre B. ;
Bulstra, Sjoerd K. ;
Vellenga, Edo ;
Mariani, Massimo A. ;
de Boer, Rudolf A. ;
van Veldhuisen, Dirk J. ;
van der Meer, Peter .
CIRCULATION-HEART FAILURE, 2018, 11 (02)
[6]   Heart Failure With Preserved Ejection Fraction [J].
Borlaug, Barry A. ;
Sharma, Kavita ;
Shah, Sanjiv J. ;
Ho, Jennifer E. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (18) :1810-1834
[7]   Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management [J].
Cappellini, Maria Domenica ;
Comin-Colet, Josep ;
de Francisco, Angel ;
Dignass, Axel ;
Doehner, Wolfram ;
Lam, Carolyn S. P. ;
Macdougall, Iain C. ;
Rogler, Gerhard ;
Camaschella, Clara ;
Kadir, Rezan ;
Kassebaum, Nicholas J. ;
Spahn, Donat R. ;
Taher, Ali T. ;
Musallam, Khaled M. .
AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (10) :1068-1078
[8]   Effect of Iron Isomaltoside on Skeletal Muscle Energetics in Patients With Chronic Heart Failure and Iron Deficiency: FERRIC-HF II Randomized Mechanistic Trial [J].
Charles-Edwards, Geoffrey ;
Amaral, Nelson ;
Sleigh, Alison ;
Ayis, Salma ;
Catibog, Norman ;
McDonagh, Theresa ;
Monaghan, Mark ;
Amin-Youssef, George ;
Kemp, Graham J. ;
Shah, Ajay M. ;
Okonko, Darlington O. .
CIRCULATION, 2019, 139 (21) :2386-2398
[9]   Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial [J].
Cleland, John G. F. ;
Kalra, Philip A. ;
Pellicori, Pierpaolo ;
Graham, Fraser J. ;
Foley, Paul W. X. ;
Squire, Iain B. ;
Cowburn, Peter J. ;
Seed, Alison ;
Clark, Andrew L. ;
Szwejkowski, Ben ;
Banerjee, Prithwish ;
Cooke, Justin ;
Francis, Mark ;
Clifford, Piers ;
Wong, Aaron ;
Petrie, Colin ;
McMurray, John J., V ;
Thomson, Elizabeth A. ;
Wetherall, Kirsty ;
Robertson, Michele ;
Ford, Ian ;
Kalra, Paul R. .
EUROPEAN HEART JOURNAL, 2024, 45 (16) :1410-1426
[10]   Defining iron deficiency in patients with heart failure [J].
Cleland, John G. F. .
NATURE REVIEWS CARDIOLOGY, 2024, 21 (01) :1-2